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ABSTRACT
The ability to verify the sequence of a nucleic acid-
based therapeutic is an essential step in the drug
development process. The challenge associated
with sequence identification increases with the
length and nuclease resistance of the nucleic acid
molecule, the latter being an important attribute of
therapeutic oligonucleotides. We describe methods
for the sequence determination of Spiegelmers,
which are enantiomers of naturally occurring RNA
with high resistance to enzymatic degradation.
Spiegelmer sequencing is effected by affixing a
label or hapten to the 50-end of the oligonucleotide
and chemically degrading the molecule in a controlled
fashion to generate fragments that are then resolved
and identified using liquid chromatography-mass
spectrometry. The Spiegelmer sequence is then de-
rived from these fragments. Examples are shown for
two different Spiegelmers (NOX-E36 and NOX-A12),
and the specificity of the method is shown using a
NOX-E36 mismatch control.
INTRODUCTION
The development of nucleic acid molecules for therapeutic
applications requires explicit conﬁrmation of their identity
as an integral part of the quality control strategy (1,2).
The techniques employed should be speciﬁc, determining
not only purity and molecular mass, but also nucleobase
sequence, nature of sugar moieties and linkages as well as
the presence of modiﬁcations (2,3). Ideally, the methods
used should also be amenable to routine testing.
Many oligonucleotide drugs undergoing clinical trials
are modiﬁed (4,5), meaning that traditional sequencing
techniques utilizing enzymes are often not effective (6,7).
Furthermore, approaches using visual readouts such as gel
electrophoresis are disfavoured due to artefacts such as
band compression caused by nucleic acid structural inﬂu-
ences (8–11). Sequence elucidation of oligonucleotides by
mass spectrometry (MS) has become the industry standard
due to its reproducibility, sensitivity and accuracy. As
such, the utilization of fragmentation patterns in MS/
MS experiments is increasingly being used, and typically
yields data sufﬁcient for sequence conﬁrmation. However,
the success of MS/MS sequencing strongly depends on the
length and nature of the oligonucleotide, with long RNA
molecules (>30nt) proving particularly challenging to
fully sequence at the current state of this method (3,12).
As such, the sequencing of long nucleic acid molecules and
their modiﬁed derivatives remains problematic. In
addition, MS/MS experiments usually provide data for
sequence conﬁrmation rather than sequence determination
(de novo sequencing) where the sequence is not known
beforehand.
RNA Spiegelmers (13,14) are structured oligonucleo-
tides of typically 30–60nt in length that possess an
L-conﬁguration, i.e. the mirror (German translation=
Spiegel) image of naturally occurring RNA. These mol-
ecules are designed to bind to target molecules with high
afﬁnity and speciﬁcity (15). Due to their L-conﬁguration,
Spiegelmers have an unprecedented stability in biological
media as nucleases and other enzymes do not recognise
or metabolise them. Due to the lack of enzymatic recog-
nition, several of the standard sequencing techniques
available for elucidating the primary structure of unmodi-
ﬁed D-RNA are not applicable to Spiegelmers. For
instance, Sanger sequencing or variations thereof cannot
be used as the polymerases employed do not recognize
L-conﬁgured nucleic acid molecules. Enzymatic stability
also prevents sequence analysis through nuclease diges-
tion. In addition, Spiegelmers are generally of a length
that exceeds the capability of current sequence conﬁrm-
ation MS/MS techniques.
Spiegelmer drugs that are currently in clinical develop-
ment are conjugated at one terminus to a 40-kDa
branched polyethylene glycol (PEG) moiety in order to
enhance the pharmacokinetic proﬁle of the molecule. As
both the polydispersity of large PEG molecules (>20kDa)
and their propensity to form adducts with cations signiﬁ-
cantly complicate their corresponding mass spectra, the
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mediate prePEG precursor. Such a strategy is valid since
the primary sequence of the Spiegelmer is not altered dur-
ing the PEGylation and subsequent processing steps. The
intermediate, prepared through standard solid support
synthesis, deprotection and puriﬁcation protocols feature
a handle, such as a primary amino modiﬁcation, upon
which the PEG moiety can be attached (Table 1).
We describe herein methods for identifying the sequence
of mirror-image RNA oligonucleotides. The L-RNA
oligonucleotide is labelled at the 50-end courtesy of the
pre-installed 50-amino functionality, and subjected to a
controlled random fragmentation process leading to frag-
ments that can be resolved and identiﬁed through liquid
chromatography (LC) and electrospray ionization–mass
spectrometry (ESI–MS). The resulting sequencing ladder
enables Spiegelmer identity elucidation through the mass
difference between sequential fragments. Due to the high
speciﬁcity and robustness of the method, it is easy to
detect point mutations or other modiﬁcations to the se-
quence or perform de novo sequencing on the RNA
oligonucleotide.
MATERIALS AND METHODS
Synthesis of amino-modiﬁed Spiegelmers
The Spiegelmers were produced by solid-phase synthe-
sis with an A ¨ kta oligopilot 100 synthesizer (GE
Healthcare, Freiburg, Germany) using 20-TBDMS RNA
phosphoramidite chemistry (16). L-rA(N-Bz)-, L-rC(Ac)-,
L-rG(N-ibu)- and L-rU- phosphoramidites were purchased
from ChemGenes (Wilmington, MA, USA). The
50-amino-modiﬁer was purchased from American
International Chemicals Inc. (Framingham, MA, USA).
Synthesis of the Spiegelmers was started on L-ribo nucleo-
side modiﬁed CPG with a pore size of 1000A ˚ (Link
Technology, Glasgow, UK). For coupling (15min per
cycle), 0.3M benzylthiotetrazole (American International
Chemicals Inc., Framingham, MA, USA) in acetonitrile
and 3.5 equivalents of the respective 0.2M phospho-
ramidite solution in acetonitrile were used. A capping–oxi-
dation–capping cycle was used. Further standard solvents
and reagents for oligonucleotide synthesis were purchased
from Biosolve (Valkenswaard, The Netherlands).
The Spiegelmers were synthesized DMT-ON; after
deprotection, the crude oligonucleotide was puriﬁed via
preparative reversed-phase high-performance liquid chro-
matography (RP-HPLC) using Source 15RPC medium
(GE Healthcare) (17). The 50-DMT-group was removed
with 80% acetic acid (90min at room temperature, RT).
Subsequently, aqueous 2M NaOAc was added and the
Spiegelmer was desalted by tangential-ﬂow ﬁltration
using a 5-kDa molecular weight cut-off (MWCO)
regenerated cellulose membrane (Millipore, Bedford,
MA, USA). Table 1 lists the all sequences that were
synthesized.
Labelling of amino-modiﬁed Spiegelmers
Labelling with cleavable biotin afﬁnity tag. Ten milligrams
(250 ODs) of amino-modiﬁed Spiegelmer were placed in a
reaction tube and dissolved in 260ml Theorell and
Stenhagen’s Universal buffer pH8.5 (33mM sodium cit-
rate, 33mM sodium phosphate, 57mM sodium borate,
pH 8.5). To this were added 200ml N,N-dimethyl-
formamide. The solution was vortexed and spun down,
whereupon 2.2mg biotin disulphide N-hydroxy-
succinimide ester (Sigma, Taufkirchen, Germany) pre-
dissolved in 50ml DMF was added. The solution was
incubated at RT for 60minutes, whereupon an aliquot
was taken and analysed by anion-exchange HPLC
[Dionex DNA-Pac 200 column, Buffer A: 100mM Tris
(Applichem, Darmstadt, Germany); 10%ACN in H2O.
Buffer B: 100mM Tris; 1M NaCl and 25mM NaClO4
(Sigma-Aldrich, Taufkirchen, Germany); 10%ACN in
H2O; both buffers were adjusted to pH8.5 with aqueous
conc. HCl (Merck, Darmstadt, Germany); gradient 10–
30% B in 6min then 30–70% B in 35min, temperature
of column 80 C] which determined that the reaction was
complete. The crude reaction mixture was desalted using a
NAP-25 column (GE Healthcare, Freiburg, Germany)
and lyophilized.
Labelling with ﬂuorescein dye. Two-hundred and twelve
ODs of aminomodiﬁed NOX-E36 (NOX-E36 Int.,
Table 1) were placed in a reaction tube and dissolved in
250mlH 2O. To this were added 3mg ﬂuorescein-
5-isothiocyanate (FITC Isomer I) (Sigma-Aldrich)
pre-dissolved in 250ml N,N-dimethylformamide. The
solution was vortexed and spun down, whereupon 6mg
sodium bicarbonate (Merck) was added. The solution was
incubated at RT for 6h, whereupon the crude mixture was
desalted by size-exclusion chromatography using an NAP-
25 column and lyophilized. The lyophilisate was
redissolved in water and puriﬁed via preparative
RP-HPLC using a Source 15RPC medium (GE
Healthcare) and was desalted via size-exclusion chroma-
tography using NAP-25 columns.
Table 1. List of Spiegelmers and the corresponding sequences
Name Sequence
NOX-E36 Int. NH2-(CH2)6-OP(O)(OH)-GCA CGU CCC UCA CCG GUG CAA GUG AAG CCG UGG CUC UGC G
NOX-E36 Int. mutant NH2-(CH2)6-OP(O)(OH)-GCA CGU CCC CUA CCG GUG CAA GUG AAG CCG UGG UCC UGC G
NOX-A12 Int. NH2-(CH2)6-OP(O)(OH)O-GCG UGG UGU GAU CUA GAU GUA UUG GCU GAU CCU AGU CAG GUA CGC
Nucleotides are depicted in bold.
Underlined sequence sections represent the CU switches of ‘NOX-E36 int. mutant’ as compared to the original sequence: ‘NOX-E36 Int.’
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Biotin-labelled Spiegelmers. To 20ml biotin-labelled
Spiegelmer (0.5OD/ml) was added 30ml sterilized water
and 2.5ml 0.5M K2CO3 (Merck) at RT. The solution was
vortexed and then incubated on an Eppendorf Thermomixer
Comfort machine (Eppendorf, Hamburg, Germany) at
70 C at 1350r.p.m. for 12.5min (NOX-E36 derivatives),
or 20min (NOX-A12) whereupon it was frozen in liquid
nitrogen and allowed to thaw out. Then 4ml 1M AcOH
was added ( pH 7) to quench the reaction and the
solution was vortexed and spun down.
FITC-labelled NOX-E36. To 13.5ml (1OD) of
FITC-labelled NOX-E36 was added 1.5ml 0.5M K2CO3
at RT. The solution was vortexed and then incubated
on an Eppendorf Thermomixer Comfort machine
(Eppendorf) at 70 C at 1350 r.p.m. for 5min whereupon
it was frozen in liquid nitrogen and allowed to thaw out.
Then 2.5ml 1M AcOH was added to quench the reaction
(ﬁnal pH & 7) and the solution vortexed, spun down and
then analysed by liquid chromatography-mass spectrom-
etry (LCMS).
Isolation of 50–fragments generated from controlled
fragmentation
Binding of biotinylated fragments to Neutravidin
beads. Neutravidin Agarose beads were treated as follows:
150ml of Neutravidin bead slurry (Pierce, Milwaukee, MI,
USA) was put in a 500-ml reaction tube. The beads were
spun down and the supernatant was carefully removed.
Whereupon 300ml 1M Tris HCl pH 8.0 (Ambion,
Huntindon, UK) was added. The slurry was vortexed,
spun down and the supernatant was carefully removed.
The beads were then washed 2 300ml in the same
manner with sterile H2O. A biotin-labelled Spiegelmer
that had undergone the controlled fragmentation
and quench was then added to the beads and the
resulting slurry was mixed vigorously (1350 r.p.m.) at
10 C for 2h.
Washing of bound fragments of NOX-E36 derivatives. The
beads with bound fragments of NOX-E36 derivatives were
isolated through ﬁltration using a spin microfuge tube
(Ultrafree-MC GV, 0.22mm; Millipore, Schwalbach,
Germany) and washed with 2 300ml sterile H2O.
Washing of bound fragments of NOX-A12. The beads with
bound fragments of NOX-A12 were spun down and the
supernatant was removed. A 1 300ml 8M urea was
added and the mixture was vortexed and spun down.
The supernatant was carefully removed and the beads
were washed a further four times with sterilized water
(200ml).
Cleavage of the biotinylated fragments from the Neutravidin
beads. The disulphide linker of the bound biotin-labelled
fragments was cleaved using a 0.05M sodium phosphate
buffer (pH 8.5), 100ml with 5ml 1M DTT solution. This
was vigorously mixed at 25 C for 2h on an Eppendorf
Thermomixer Comfort machine. The slurry was ﬁltered
using a spin microfuge tube (Ultrafree-MC GV, 0.22mm;
Millipore), and the beads were washed with a further 50ml
sterile water. A UV measurement was taken to determine
the optical density units at 260nm, and 0.25ODs of this
solution was analysed by LCMS.
LCMS analysis of fragments for Spiegelmer identiﬁcation
Analysis of Spiegelmer fragments generated from the
protocols above were analysed using an LCMS system
(Agilent Technologies, Waldbronn, Germany) comprised
of a 1200-series rapid resolution pump, autosampler with
sample cooler (set to 6 C), column oven set to 65 C
equipped with a six-port valve, Diode Array Detector
(DAD) and a 6520 Quadrupole-Time Of Flight (Q-TOF)
mass spectrometer equipped with electrospray ionization
source. Data were acquired in the negative ion mode
between m/z 50 and 3200. The gas temperature was
350 C, drying gas ﬂow 12l/min., nebulizer pressure
60PSI, capillary voltage 4000V, and fragmentation volt-
age was set to 350V. For separation, an Acquity BEH C18
Column (1.7mm, 130 A ˚ pore size, 2.1 30mm; Waters,
Eschborn, Germany) operated at a ﬂow rate of 0.2ml/min.
has been used.
The sample was analysed by injecting and trapping the
Spiegelmer fragments onto the LC column while
non-volatile salts were eluted to waste via the DAD and
the six-port valve. After this desalting process (0.5min),
the efﬂuent was delivered to the ESI-MS by switching the
six-port valve. A gradient was run from 0–20% B in 0.5 to
22min, 20–30% B in 40min. Buffer A consisted of 1%
methanol and 100mM hexaﬂuoroisopropanol (Biosolve),
10mM ethylenediaminetetraacetic acid (EDTA) (NH4
+
form) and 10mM Triethylamine (Sigma-Aldrich) in
water. Buffer B consisted of 10mM Triethylamine,
100mM hexaﬂuoroisopropanol, 10mM EDTA (NH4
+
form) and 50% methanol in water. For fragments that
originated from biotinylated Spiegelmer, mass spectra
from the total ion chromatogram (TIC) were derived for
each peak and then deconvoluted. For fragments that
originated from FITC-NOX-E36, the mass spectra from
the TIC were derived for each peak observed in the UV
chromatogram extracted at 495nm, and then
deconvoluted.
Deconvolution for smaller fragments was performed
using resolved isotope deconvolution, whereby the mono-
isotopic mass has been reported up to a molecular weight
where the monoisotopic mass could be clearly identiﬁed.
The exact Spiegelmer fragment monoisotopic mass could
be identiﬁed up to 5–8kDa, depending on signal intensity.
For larger Spiegelmer fragments, average mass deconvo-
lution was applied (mass step 1.0, varying deconvolution
range and varying m/z range depending on Spiegelmer
fragment envelope).
RESULTS AND DISCUSSION
Initial attempts to conﬁrm sequence identity of
Spiegelmers focused on using state-of-the-art MS/MS
techniques on the amino-modiﬁed precursor of exemplary
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whole sequence, leaving a gap of 10–15nt in the middle
unidentiﬁed (data not shown). Recent advancements in
MS/MS techniques have enabled longer RNA molecules
to be sequenced (12).
It was therefore deemed necessary to break the Spiegelmer
molecule into fragments, but the ability to connect these
fragments to provide a sequencing ladder is required to
provide the complete primary structure. Although it has
been shown that L-oligonucleotides have a limited lability
towards Snake Venom Phosphodiesterase (18), sequential
degradation, as reported for D-RNA (19) with this
enzyme, would require very long incubation times, thus
making this route unfeasible. However, Spiegelmers are
susceptible to chemical degradation to the same extent
as the corresponding D-nucleic acid material. Chemical
sequencing of RNA has been previously reported by the
use of nucleobase speciﬁc chemical reactions that can be
used to effect strand scission at speciﬁc sites along the
nucleotide backbone (20). However, this approach was
disfavoured due to the many reactions required, the lack
of absolute nucleobase speciﬁcity and the potential for
artefactual results by virtue of the nucleobase modiﬁcation
and cleavage steps.
Chemical cleavage of RNA can be effected with acidic
or basic solutions. This indiscriminate cleavage creates a
mix of fragments representing random strand scission 30 to
every nucleotide, resulting in the formation of 50,3 0 and
internal fragments. In order to extract a meaningful
pattern that would yield a sequencing ladder, it occurred
to us that the pre-existence of the 50-amino functionality
on the non-PEGylated Spiegelmer intermediate could be
exploited by attaching an afﬁnity tag (ligand) hapten to it.
Upon careful fragmentation of the Spiegelmer, labelled
species could be subsequently isolated e.g. through immo-
bilization. Non-labelled species, in this case 30- and
internal fragments, could be washed away, and the
bound fragments then released from the support providing
a sequencing ladder of 50-fragments that could be analysed
further with LC coupled to MS. The LC-MS approach
Figure 1. Schematic of proof of principle evaluation with NOX-E36-Int. 50–fragments in this schematic have been encompassed using the formula
‘R’-NH-(CH2)6-OP(O)(OH)-G(X)ycp where ‘R’ is either the structurally drawn cleavable biotin afﬁnity tag or cleaved fragment. Letters in bold and
underlined, respectively, represent the nucleic acid sequence, X indicates the identity of the particular nucleotide (A, C, G, U) read from the sequence
50-t o3 0- and y represents how many additional nucleotides are in the fragment over the ﬁrst fragment. For example, for fragment 2: y=1 (one extra
nucleotide). The extra nucleotide(s) X over the ﬁrst fragment is one (C) therefore the fragment, fragment 2 is ‘R’-NH-(CH2)6-OP(O)(OH)-GCcp. The
annotation cp in subscript denotes 2030 cyclic phosphate. The L-RNA sequence of the Spiegelmer is in bold letters. FLP=Full Length (undegraded)
Product.
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cilitates the identiﬁcation of the individual fragments by
attributing corroborating properties to the fragments e.g.
the tendency for longer oligonucleotide fragments to have
a longer column retention time than shorter oligonucleo-
tide fragments, and the separation of the fragments would
promote their isolated analysis by ESI-MS, thus
minimizing ion-suppression phenomena due to co-eluting
compounds.
As proof of principle, 50-aminomodiﬁed NOX-E36
intermediate (NOX-E36 Int.) was labelled with
(2-[Biotinamido]ethylamido)-3,30-dithiodipropionic acid
N-hydroxysuccinimide ester (see Figure 1 for schematic)
in the universal buffer of Theorell & Stenhagen adjusted
Figure 2. This ﬁgure shows the UV (260nm) (A) and total ion chromatogram (TIC) (B) obtained from the LC-MS experiment after biotin labelled
NOX-E36 Int. was subjected to the sequencing protocol as described. The former after sequence conﬁrmation is annotated (C), to show the position/
retention time of the fragments.
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disulphide bond that can be cleaved under mild condi-
tions. After desalting the crude mixture using a size-
exclusion column, the material was chemically cleaved in
a random fashion with 25mM potassium carbonate at
70 C. The cleavage time was carefully optimized so as
not to drive the cleavage to completion, and to ensure that
sufﬁcient amounts of fragments are generated. Optimal
cleavage times lengthened with an increase in Spiegelmer
concentration and purity, and varied according to
Spiegelmer sequence and salt content. Upon reaching
the desired incubation time, solutions were quenched by
snap cooling with liquid nitrogen and then the basic
solution was neutralised with aqueous acetic acid. This
was found to be a milder, more reliable quenching
method than simply adding the quenching solution to
the hot solution.
Subsequent to the fragmentation and quench, which
produces 50-fragments, 30-fragments, and random internal
fragments of NOX-E36 Int., the resulting solution was
then incubated with Neutravidin beads whereby the
50-(biotinylated) fragments and remaining intact bio-
tinylated NOX-E36 Int. (i.e. full-length product) are se-
lectively immobilized on the beads by virtue of the hapten
biotin. The unbound fragments, i.e. 30-fragments and
random internal fragments that do not possess the afﬁnity
tag, are then washed away. Release of the immobilized
fragments by cleaving the internal disulphide bond of
the label’s linker under mild reducing conditions (50mM
DTT in 50mM sodium phosphate buffer) furnished
the corresponding thiol derivatives of the fragments
(Figure 1). The liberated fragments were then analysed
by LC-MS using a Q-TOF electrospray ionization mass
spectrometer. The UV and total ion chromatogram (TIC)
both show discrete peaks that correspond to derivatives of
all labelled species: 50-fragments and undegraded NOX-
E36 Int. (Figure 2). The exact or average mass(es)
observed in the discrete peaks were obtained through de-
convolution of the derived mass spectra pertaining to each
discrete peak (see Figure 3 for an exemplary spectrum).
Where possible, monoisotopic resolved masses were
obtained, otherwise the corresponding average molecular
mass values were acquired.
As previously mentioned, the LC-ESI-MS approach
facilitates fragment identity conﬁrmation/elucidation. It
is of interest to note that unlike other sequencing methods
(3,21,22), all fragments are retained on the column and all
information is available in one LC-MS measurement. This
signiﬁcantly improves method robustness and conveni-
ence. Some fragments co-elute with the full-length product
(FLP). Due to the phenomenon of ion suppression, this
can impact on the sensitivity or accuracy of the data ac-
quisition of low-abundant species. However, this can be
overcome by controlling the fragmentation time so that
the FLP:N-1 or N-2 ratio is optimal. Interestingly, in this
LC method, the penultimate fragment of NOX-E36 elutes
later than the FLP. This can be readily explained by
taking into account the relative phosphate charges (and
hence ion pairs with the buffer) and the number of
nucleobases. For fragment 39, the number of phosphates
is equal to the FLP but it possesses one nucleobase less (in
this case a guanosine).
In general, the masses observed are those of the
20,30-cyclic phosphates. As expected, fragment mass in-
creases with an increase in retention time. The exception
to this rule is the presence of low abundance of fragments
whereby the cyclic phosphate has been hydrolysed. The
hydrolysed 20 (30) phosphate derivatives, which further
conﬁrm the identity of the fragments generated, typically
elute later than the parent 20,30-cyclic phosphate and often
Figure 3. Deconvoluted molecular weight of a fragment (mass peak value=10237.26Da), in this case Fragment 31.
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ments’ cyclic phosphate derivative. This is presumably
due to the added charge/ion pair generated by the
hydrolysis.
The masses of the fragments generated can be compared
to the calculated masses of the predicted 50–fragments of
the thiol-derived NOX-E36 intermediate to conﬁrm the
sequence (Table 2). Alternatively, by virtue of the
sequencing ladder generated, Spiegelmer identity can be
derived without prior knowledge of the sequence due to
the differences between the fragments generated (sequence
ladder). In this scenario, the ﬁrst fragment of the nucleic
acid molecule, representing the terminal 50-nucleotide, can
be predicted and veriﬁed, and the incremental differences
of the subsequent fragments reveal their identity. A target
mass list that can be used for de novo sequencing of
Spiegelmers using the aforementioned biotin method is
depicted in Table 3. When employing this de novo
method, the incremental difference between fragments is
derived using the calculated mass of the (elucidated)
previous fragment. This prevents accumulations of experi-
mental errors (e.g.  0.2-Da error followed by a+0.2-Da
error) that may exceed the threshold for unambiguous
discrimination between a ribo-C and ribo-U nucleoside,
whose masses differ by just 1Da. Employing either data
processing method readily conﬁrmed the sequence of
NOX-E36 within the required accuracy range.
To demonstrate the selectivity of the method, and the
ability to sequence de novo, an amino-modiﬁed NOX-E36
derivative that has a UC and a CU switch in the
Table 2. Sequence conﬁrmation of NOX-E36 Int
Fragment
a/RT (min) Structure
b Observed (Da) Calculated (Da)
1/3.57 R-Gcp 612.12 612.12
2/4.85 R-GCcp 917.16 917.16
3/8.65 R-GCAcp 1246.21 1246.21
4/11.49 R-GCACcp 1551.25 1551.25
5/14.53 R-GCACGcp 1896.30 1896.30
6/16.99 R-GCACGUcp 2202.32 2202.32
7/18.91 R-GCACGUCcp 2507.36 2507.37
8/20.53 R-GCACGUCCcp 2812.40 2812.41
9/21.88 R-GCACGUCCCcp 3117.44 3117.45
10/23.07 R-GCACGUCCCUcp 3423.46 3423.47
11/24.08 R-GCACGUCCCUCcp 3728.51 3728.52
12/25.50 R-GCACGUCCCUCAcp 4057.55 4057.57
13/26.13 R-GCACGUCCCUCACcp 4362.60 4362.61
14/26.81 R-GCACGUCCCUCACCcp 4667.64 4667.65
15/27.73 R-GCACGUCCCUCACCGcp 5012.68 5012.70
16/28.67 R-GCACGUCCCUCACCGGcp 5357.72 5357.75
17/29.52 R-GCACGUCCCUCACCGGUcp 5663.75 5663.77
18/30.53 R-GCACGUCCCUCACCGGUGcp 6008.81 6008.82
19/31.45 R-GCACGUCCCUCACCGGUGCcp 6313.85 6313.86
20/33.25 R-GCACGUCCCUCACCGGUGCAcp 6642.90 6642.91
21/34.91 R-GCACGUCCCUCACCGGUGCAAcp 6971.96 6971.96
22/35.84 R-GCACGUCCCUCACCGGUGCAAGcp 7317.01 7317.01
23/36.72 R-GCACGUCCCUCACCGGUGCAAGUcp 7623.05 7623.04
24/37.79 R-GCACGUCCCUCACCGGUGCAAGUGcp 7968.13 7968.08
25/39.53 R-GCACGUCCCUCACCGGUGCAAGUGAcp 8297.15 8297.14
26/41.13 R-GCACGUCCCUCACCGGUGCAAGUGAAcp 8626.19 8626.19
27/41.81 R-GCACGUCCCUCACCGGUGCAAGUGAAGcp 8971.29 8971.24
28/42.51 R-GCACGUCCCUCACCGGUGCAAGUGAAGCcp 9276.31 9276.28
29/43.26 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCcp 9581.24 9581.32
30*/44.18 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGcp 9931.04 9931.02
31*/44.89 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUcp 10237.26 10237.19
32*/45.69 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGcp 10582.54 10582.40
33*/46.43 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGcp 10927.70 10927.60
34*/47.05 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCcp 11232.86 11232.78
35*/47.65 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCUcp 11538.97 11538.95
36*/48.23 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCUCcp 11844.12 11844.13
37*/48.71 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCUCUcp 12150.36 12150.29
38*/49.06 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCUCUGcp 12495.72 12495.50
39*/49.79 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCUCUGCcp 12800.76 12800.68
FLP*/49.06 R-GCACGUCCCUCACCGGUGCAAGUGAAGCCGUGGCUCUGCG 13083.85 13083.92
This table shows the retention time, structure and deconvoluted observable masses (exact or average) obtained from the TIC along with the
corresponding calculated values of the expected fragments.
aFragment number (in bold) corresponds to fragment size according to the sequence.
bStructure and sequence of fragments: R=HS-(CH2)2C(O)-NH(CH2)6-OP(O)(OH)-, cp in subscript annotation denotes 2030–cyclic phosphate,
L-RNA sequence of Spiegelmer is in bold letters; FLP=Full Length (undegraded) Product.
All masses observed are exact isotopic masses unless indicated (*) whereby the observed mass is the corresponding average molecular mass.
Calculated masses are switched to average molecular weight accordingly.
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mutant, was synthesized. Due to the 1-Da difference, the
cytosine/uridine switch is the most challenging to detect
and therefore such a switch was placed at both ends of
the molecule. This derivative was processed in an identical
manner to NOX-E36 Int as previously described. Figure 4
shows the corresponding TIC displaying the fragments.
Masses were obtained from all fragments, and using the
‘Target Mass list’ (Table 3), Fragment 1 and hence the ﬁrst
nucleotide was readily identiﬁed within the allowed error
margin. As depicted in Table 4, the calculated value of this
now elucidated fragment is used as a reference for the next
fragment. Hence, the identity of the second nucleotide is
obtained by subtracting the observed mass of Fragment 2
from the calculated mass of the previous elucidated
fragment, Fragment 1. In an iterative process, once the
identity of the second nucleotide has been elucidated, the
theoretical mass of this fragment is calculated and used for
the identiﬁcation of the third fragment. This process con-
tinues up to the last nucleotide, whereby the mass differ-
ence here amounts to the value of the nucleoside itself due
to a lack of 30-cyclic phosphate (see Table 3). As can be
seen in Table 4, following a de-novo sequencing protocol,
both switches were readily identiﬁed.
The method was applied to another L-RNA oligo-
nucleotide, Spiegelmer NOX-A12 Int (for sequence, see
Table 1). Here, the protocol needed to be altered slightly
to accommodate the new sequence. Firstly, it was found
that NOX-A12 required a longer fragmentation time
(20min. versus 12.5min. for NOX-E36). Secondly, the
bead-washing protocol after immobilization of the
biotin-labelled fragments also needed to be altered as it
was found that washing the beads with water and subse-
quent fragment release did not remove all unlabelled frag-
ments. This phenomenon was probably caused by
self-aggregation of the molecule whereby non-labelled
fragments aggregated with labelled immobilized frag-
ments and were therefore not removed by the
washing step (Figure 5). By using a chaotrope, in this
case 8M urea aqueous solution, to disrupt this hydrogen
bonding, the non-labelled fragments could be successfully
removed (Figure 6). A sequencing ladder and subsequent
elucidation were readily obtained (see Supplementary
Table 1).
It occurred to us that the presumption that physical
isolation of a set of fragments (e.g. via immobilization)
is a critical element for a successful sequencing process
could be challenged. The origins of this presumption lies
in the knowledge that all fragments, be they 50-, 30-o r
internal fragments, provide mass data, which would con-
found the generation of a sequencing ladder. However, by
attaching a label to the NOX-E36 Int. such as a ﬂuores-
cein dye label, 50-fragments could be resolved by using an
alternative detection wavelength. At this wavelength, a
ladder depicting all possible 50-fragments can be selectively
observed and mass data at the corresponding retention
times in the (TIC) can be generated.
To demonstrate the feasibility of this method, a
ﬂuorescein-5-isothiocyanate (FITC Isomer I) label was
attached to NOX-E36 Int. The FITC-labelled NOX-E36
Int. was then subjected to controlled fragmentation and
the sample analysed by LC-MS. The label has a selective
wavelength absorbance at 495nm. Therefore, at 495nm,
only nucleic acid molecules containing an intact 50-end
Figure 4. TIC obtained from NOX-E36 Int. mutant (Table 1) after sequencing protocol (from labelling to analysis) has been carried out.
Table 3. Target Mass list for de novo sequencing using the immobil-
ization method exempliﬁed in Figure 1
Nucleoside Fragment 1  mass
(Fa+1 – Fa)
 mass
(FLP – Fp)
Exact Average Exact Average Exact Average
A 596.12 596.49 329.05 329.21 267.10 267.24
C 572.11 572.46 305.04 305.18 243.09 243.22
G 612.12 612.49 345.05 345.21 283.09 283.24
U 573.09 573.45 306.03 306.17 244.07 244.20
All values are in daltons.
Fragment 1 is the smallest 50–fragment, masses displayed are those of
the cyclic phosphate derivative.
‘ mass (Fa+1 –F a)’ denotes the mass difference between sequential
2030–cyclic phosphate containing fragments i.e. where ‘a+1’ is not the
Full Length (undegraded) Product (FLP).
‘ mass (FLP–Fp)’ denotes the mass difference attributable to the
30–terminal nucleoside.
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intact-labelled NOX-E36 Int.) will be observed. As can
be seen from Figure 7A, the chromatogram looks very
similar to that observed from the biotin-immobilization
method (Figures 2, 4 and 6). However, comparing this
UV chromatogram extracted at 495nm with the cor-
responding UV chromatogram extracted at 260nm
(Figure 7B) it can be clearly seen that there are many
other fragments present. Moreover, a comparison of the
UV chromatogram extracted at 260nm with the TIC
(Figure 7C) shows that the two chromatograms are very
similar, thus all fragments either with or without label
generate mass data.
As determined through the chromatogram extracted at
495nm, the ﬁrst 50-fragment [representing in this example
FITC-NH-(CH2)6-OP(O)(OH)-Gcp where cp is 20,30-cyclic
phosphate] can be readily identiﬁed to be that eluting at
6.31min (Figure 7A and enlargement Figure 8). It can also
be clearly seen by comparing the TIC and the extracted
495nm chromatogram that there are many non-labelled
fragments that elute earlier than this peak; however, these
represent fragments of between 8 and 14nt in length as
Table 4. De novo sequencing of ‘NOX-E36 Int. mutant’ (Table 1) readily reveals both CU mutations compared to the parent NOX-E36 Int.
Spiegelmer
Fragment # RT in
TIC
a
(min)
Type of
Observable
mass
Deconvoluted
Observed
mass (Da)
Mass
b
(Da)
Mass
identiﬁed as
c
Calculated mass
d Absolute
error
e (Da)
Exact (Da) Average (Da)
1 3.87 Exact 612.12 612.12 G 612.12 – 0.00
2 5.17 Exact 917.16 305.04 C 917.16 – 0.00
3 9.02 Exact 1246.21 329.05 A 1246.21 – 0.00
4 11.84 Exact 1551.25 305.04 C 1551.25 – 0.00
5 14.84 Exact 1896.30 345.05 G 1896.30 – 0.00
6 17.25 Exact 2202.32 306.02 U 2202.32 – 0.00
7 19.14 Exact 2507.36 305.05 C 2507.37 – 0.01
8 20.73 Exact 2812.40 305.03 C 2812.41 – –0.01
9 22.08 Exact 3117.44 305.03 C 3117.45 – –0.01
10 23.21 Exact 3422.48 305.03 C 3422.49 – –0.01
11 24.26 Exact 3728.51 306.02 U 3728.52 –  0.01
12 25.65 Exact 4057.56 329.04 A 4057.57 – –0.01
13 26.29 Exact 4362.60 305.03 C 4362.61 – –0.01
14 26.98 Exact 4667.64 305.03 C 4667.65 – –0.01
15 27.87 Exact 5012.68 345.03 G 5012.70 – –0.02
16 28.76 Exact 5357.74 345.04 G 5357.75 – –0.01
17 29.61 Exact 5663.75 306.00 U 5663.77 – –0.02
18 30.59 Exact 6008.80 345.03 G 6008.82 – –0.02
19 31.47 Exact 6313.86 305.04 C 6313.86 – 0.00
20 33.23 Exact 6642.92 329.06 A 6642.91 – +0.01
21 34.84 Exact 6971.96 329.05 A 6971.96 – 0.00
22 35.73 Exact 7316.99 345.03 G 7317.01 – –0.02
23 36.58 Exact 7623.02 306.01 U 7623.04 – –0.02
24 37.62 Exact 7968.07 345.03 G 7968.08 – –0.01
25 39.32 Exact 8297.13 329.05 A 8297.14 – –0.01
26 40.88 Exact 8626.23 329.09 A 8626.19 – +0.04
27 41.56 Exact 8971.30 345.11 G 8971.24 – +0.06
28 42.22 Exact 9276.28 305.04 C 9276.28 – 0.00
29 42.95 Exact 9581.26 304.98 C 9581.32 – –0.06
30 43.84 Exact 9926.35 345.03 G 9926.37 9931.02 –0.02
31 44.54 Average 10237.26 306.24 U – 10237.19 +0.07
32 45.31 Average 10582.53 345.34 G – 10582.40 +0.13
33 46.09 Average 10927.69 345.29 G – 10927.60 +0.09
34 46.66 Average 11233.75 306.15 U – 11233.77 –0.02
35 47.21 Average 11538.95 305.18 C – 11538.95 0.00
36 47.76 Average 11844.25 305.30 C – 11844.13 +0.12
37 48.28 Average 12150.34 306.21 U – 12150.29 +0.05
38 48.58* Average 12495.64 345.35 G – 12495.50 +0.14
39 49.26** Average 12800.80 305.30 C – 12800.68 +0.12
FLP 48.58 Average 13084.04 283.36 G – 13083.92 +0.12
aRetention time values are those taken from the TIC.
b mass is calculated by subtracting the calculated mass value of the previous fragment from the observed value.
cSee Table 3 for cipher.
dCalculated mass values are obtained by calculating the theoretical mass of the conﬁrmed sequence.
eAbsolute error is calculated by subtracting the target  mass value (Table 3) from the  mass value obtained.
*Fragment 38 co-elutes with the full-length (undegraded) released product (FLP). **Fragment 39 has a retention time greater than the FLP, which in
this case is HS-(CH2)2C(O)-NH(CH2)6-OP(O)(OH)-GCACGUCCCCUACCGGUGCAAGUGAAGCCGUGGUCCUGCG.
The C/U switches compared to ‘NOX-E36 Int.’ (Table 1) are highlighted (bold).
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due to the lipophilicity afforded to the labelled fragments,
any non-labelled fragment that co-elutes with the labelled
fragments can be disregarded due to the signiﬁcant differ-
ence in mass to that expected for a particular fragment size
(>2kDa). This is clearly illustrated in Figure 9, where
the extracted wavelength of 495nm represents the FITC-
labelled 50-fragments; the extracted wavelength of 260nm
represents all nucleic acid fragments, as does the TIC. By
obtaining a mass spectrum for the ions within the range
marked by the two dotted lines in Figure 9 that represent a
typical ion window for obtaining the mass spectrum of the
labelled fragment (Figure 10), more than one peak is
obtained upon deconvolution. As the peaks vary greatly
in mass value, only one is feasible as coming from the
labelled fragment, in this case the average molecular
mass deconvoluted value of 4666Da. This ability to
discount spurious masses enables the generation of the
sequencing ladder required for Spiegelmer identiﬁcation,
and can therefore be also used for de novo sequencing (see
Supplementary Tables 2 and 3).
CONCLUSION
In conclusion, we have developed effective and robust
methods for the elucidation of mirror-image RNA-
oligonucleotide (Spiegelmer) primary structures. The
methods employed take advantage of the amino-handle
pre-installed on the Spiegelmer intermediate by attaching
either an afﬁnity tag or a dye label to it. This mild pro-
cedure can be done on puriﬁed and also crude material if
required, and can be used for sequencing after a rudimen-
tary desalting procedure. Chemical fragmentation of the
labelled molecule under mild basic conditions serves to
reduce the chance of artefactual fragments being
produced, and either isolating or resolving the labelled
fragments creates the sequencing ladder needed for struc-
ture identiﬁcation. In the case of immobilization, it was
found that washing immobilized fragments with a chao-
tropic solution served to remove co-isolated unlabelled
fragments, thus suppressing contamination arising from
this phenomenon, the extent of which was sequence
dependent.
Figure 5. TIC of NOX-A12 sequencing using NOX-E36 washing protocol reveals non-labelled fragments have been co-immobilized with the labelled
fragments.
Figure 6. TIC of NOX-A12 sequencing using improved chaotropic washing protocol with 8M urea. Chromatogram reveals non-labelled fragments
that in previous protocol were bound to the immobilized 50–fragments and therefore co-isolated have been successfully washed away.
e147 Nucleic Acids Research, 2011,Vol.39, No. 21 PAGE 10 OF 13Figure 7. LC-MS analysis of FITC-labelled NOX-E36 Int. after controlled fragmentation. (A) UV chromatogram extracted at 495nm revealing just
50–fragments; (B) UV chromatogram extracted at 260nm revealing all nucleic acid fragments; (C) TIC showing all ions present.
Figure 8. Zoomed view of Figure 7 showing the location of the ﬁrst two labelled fragments in the TIC (A), as revealed in the extracted wavelength
chromatogram at 495nm (B), as highlighted with the dotted-line arrows. Fragments i, iii, and v with deconvoluted isotopic masses of 4106.55,
4451.60 and 4780.64Da, respectively, have molecular masses far greater than those expected for the ﬁrst two labelled fragments with similar retention
time ii and iv, which have the expected values of 913.15 and 1218.19Da, respectively.
PAGE 11 OF 13 Nucleic Acids Research, 2011,Vol.39, No. 21 e147The methods described herein were proven to meet se-
lectivity and accuracy requirements as shown by suc-
cessfully testing the method on a mutant (isomeric)
NOX-E36 Int. derivative with two CU switches
compared to the parent compound. Consequently, the
method can be readily applied to the de novo sequencing
of mirror-image RNA-oligonucleotides. It should also
be noted that the ability to generate all desired frag-
ments in one step and for those fragments to be resolved
in one LC-MS measurement serves to enhance the ro-
bustness and convenience of the method, as does the
avoidance of MS/MS experiments and their subse-
quent interpretation. Furthermore, the method is also
applicable to other RNA molecules with the ability to
install reactive handles and linkers onto unmodiﬁed
nucleic acids (23), making the technique more widely
applicable.
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Figure 9. Zoomed view of Figure 7 (16.6–18.5min) illustrating FITC-labelled and non-FITC-labelled fragments co-eluting. The extracted
wavelength chromatogram at 495nm shows FITC-labelled nucleic acid fragments, the extracted wavelength chromatogram at 260nm indicates all
nucleic acid fragments (labelled and non-labelled) and the TIC displays all ions in the sample material. It is clear to see that in the marked area
between the dotted lines there are other species present that produce ions alongside the labelled fragment with the retention time of 17.54min.
Figure 10. Deconvoluted mass spectrum of the area in the TIC in Figure 9 between the dotted lines. Out of the masses observed, only one peak has
a mass value that would be plausible for the following fragment in the sequencing ladder ( range: 305–345Da). Nonsensical masses can therefore be
identiﬁed as non-labelled fragments.
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